Zobrazeno 1 - 10
of 370
pro vyhledávání: '"Nyaku, M"'
Autor:
Boehme A; Aetion Inc., New York, NY, United States., Harvey RA; Johnson & Johnson Innovative Medicine, Spring House, PA, United States., Madsen A; Aetion Inc., New York, NY, United States., Rubens L; Aetion Inc., New York, NY, United States., Toyip A; Aetion Inc., New York, NY, United States., Batech M; Aetion Inc., New York, NY, United States., Ricci D; Johnson & Johnson Innovative Medicine, Spring House, PA, United States., Nyaku M; Johnson & Johnson Innovative Medicine, Spring House, PA, United States.
Publikováno v:
Frontiers in public health [Front Public Health] 2024 Dec 04; Vol. 12, pp. 1501919. Date of Electronic Publication: 2024 Dec 04 (Print Publication: 2024).
Autor:
MARSH, Z. A., GRYTDAL, S. P., BEGGS, J. C., LESHEM, E., GASTAÑADUY, P. A., RHA, B., NYAKU, M., LOPMAN, B. A., HALL, A. J.
Publikováno v:
Epidemiology and Infection, 2018 Jan 01. 146(2), 159-167.
Externí odkaz:
https://www.jstor.org/stable/26523206
Autor:
Baxter L; Department of Paediatrics, University of Oxford, Oxford, UK., Slater R; Department of Paediatrics, University of Oxford, Oxford, UK., Hermany L; Merck & Co., Inc, North Wales, Pennsylvania, USA., Bhatti A; Merck & Co., Inc, Kenilworth, New Jersey, USA., Eiden AL; Merck & Co., Inc, Kenilworth, New Jersey, USA., Mitrovich R; Merck & Co., Inc, Kenilworth, New Jersey, USA., Connolly MP; University of Groningen, Groningen, The Netherlands., Vanderslott S; Department of Paediatrics, University of Oxford, Oxford, UK., Nyaku M; Merck & Co., Inc, Kenilworth, New Jersey, USA., Bhatt A; Department of Paediatrics, University of Oxford, Oxford, UK aomesh.bhatt@paediatrics.ox.ac.uk.
Publikováno v:
BMJ open [BMJ Open] 2024 May 28; Vol. 14 (5), pp. e072794. Date of Electronic Publication: 2024 May 28.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Connolly MP; Health Economics, Global Market Access Solutions LLC, Mooresville, North Carolina, United States of America.; University Medical Center Groningen, Groningen, Netherlands., Kotsopoulos N; Health Economics, Global Market Access Solutions LLC, Mooresville, North Carolina, United States of America.; Department of Economics, University of Athens, Athens, Greece., Roberts C; Merck & Co., Inc., Center for Observational and Real-World Evidence, Kenilworth, New Jersey, United States of America., Kotlikoff L; Department of Economics, Boston University, Boston, Massachusetts, United States of America., Bloom DE; Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America., Hu T; Merck & Co., Inc., Center for Observational and Real-World Evidence, Kenilworth, New Jersey, United States of America., Nyaku M; Merck & Co., Inc., Center for Observational and Real-World Evidence, Kenilworth, New Jersey, United States of America.
Publikováno v:
PLOS global public health [PLOS Glob Public Health] 2023 Oct 18; Vol. 3 (10), pp. e0002461. Date of Electronic Publication: 2023 Oct 18 (Print Publication: 2023).
Autor:
Fues Wahl H; Quantify Research, Stockholm, Sweden., Wikman Erlandson B; MSD, Stockholm, Sweden., Sahlin C; Quantify Research, Stockholm, Sweden., Nyaku M; Merck & CO., Inc, Kenilworth, NJ, USA., Benĉina G; Center for Observational and Real-World Evidence, MSD, Madrid, Spain.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Dec 31; Vol. 18 (1), pp. 2026711. Date of Electronic Publication: 2022 Feb 01.
Autor:
Mauskopf J; Department of Health Economics, RTI Health Solutions, Research Triangle Park, NC, USA., Blake L; Department of Health Economics, RTI Health Solutions, Research Triangle Park, NC, USA., Eiden A; Center for Observation and Real-World Evidence, Merck & Co, Inc, Kenilworth, NJ, USA., Roberts C; Center for Observation and Real-World Evidence, Merck & Co, Inc, Kenilworth, NJ, USA., Hu T; Center for Observation and Real-World Evidence, Merck & Co, Inc, Kenilworth, NJ, USA., Nyaku M; Center for Observation and Real-World Evidence, Merck & Co, Inc, Kenilworth, NJ, USA. Electronic address: mawuli.nyaku@merck.com.
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2022 May; Vol. 25 (5), pp. 810-823. Date of Electronic Publication: 2022 Jan 10.
Autor:
Silver MC; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, USA. Electronic address: Msilver@hsph.harvard.edu., Neumann PJ; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, USA., Ma S; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, USA., Kim DD; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, USA., Cohen JT; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, USA., Nyaku M; Merck & Co., Inc., Kenilworth, NJ, USA., Roberts C; Merck & Co., Inc., Kenilworth, NJ, USA., Sinha A; Merck & Co., Inc., Kenilworth, NJ, USA., Ollendorf DA; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, USA.
Publikováno v:
Vaccine [Vaccine] 2021 Nov 05; Vol. 39 (46), pp. 6727-6734. Date of Electronic Publication: 2021 Oct 14.
Autor:
Nyaku M; From the Merck & Co., Inc., Kenilworth, New Jersey., Richardson E; From the Merck & Co., Inc., Kenilworth, New Jersey., Martinon-Torres F; Translational Pediatrics and Infectious Diseases, Hospital Clínico Universitario and Universidad de Santiago de Compostela (USC), Galicia, Spain.; Genetics, Vaccines, and Pediatric Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago and Universidad de Santiago de Compostela (USC), Galicia, Spain., Kuter BJ; From the Merck & Co., Inc., Kenilworth, New Jersey.
Publikováno v:
The Pediatric infectious disease journal [Pediatr Infect Dis J] 2021 Nov 01; Vol. 40 (11), pp. 1046-1054.
Autor:
Tchoualeu DD; Global Immunization Division, Center for Global Health, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA. Dtchoualeu@cdc.gov., Harvey B; Global Immunization Division, Center for Global Health, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA., Nyaku M; Global Immunization Division, Center for Global Health, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA., Opare J; African Field Epidemiology Network, Accra, Ghana., Traicoff D; Global Immunization Division, Center for Global Health, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA., Bonsu G; Ghana Health Service, Public Health Division, Disease Control and Prevention Department, Expanded Programme on Immunization, Korle Bu, Accra, Ghana., Quaye P; Ghana Health Service, Public Health Division, Disease Control and Prevention Department, Expanded Programme on Immunization, Korle Bu, Accra, Ghana., Sandhu HS; Global Immunization Division, Center for Global Health, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.
Publikováno v:
Global health, science and practice [Glob Health Sci Pract] 2021 Sep 30; Vol. 9 (3), pp. 498-507. Date of Electronic Publication: 2021 Sep 30 (Print Publication: 2021).